- Home
- SBUX vs BMY Comparison
SBUX vs BMY Comparison
Compare SBUX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBUX
- BMY
- Stock Information
- Founded
- SBUX 1971
- BMY 1887
- Country
- SBUX United States
- BMY United States
- Employees
- SBUX N/A
- BMY N/A
- Industry
- SBUX Restaurants
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- SBUX Consumer Discretionary
- BMY Health Care
- Exchange
- SBUX Nasdaq
- BMY Nasdaq
- Market Cap
- SBUX 127.3B
- BMY 120.5B
- IPO Year
- SBUX 1992
- BMY N/A
- Fundamental
- Price
- SBUX $81.50
- BMY $49.23
- Analyst Decision
- SBUX Buy
- BMY Hold
- Analyst Count
- SBUX 23
- BMY 15
- Target Price
- SBUX $104.00
- BMY $57.79
- AVG Volume (30 Days)
- SBUX 12.8M
- BMY 14.6M
- Earning Date
- SBUX 04-29-2025
- BMY 04-24-2025
- Dividend Yield
- SBUX 2.99%
- BMY 5.04%
- EPS Growth
- SBUX N/A
- BMY N/A
- EPS
- SBUX 3.10
- BMY N/A
- Revenue
- SBUX $36,148,700,000.00
- BMY $48,300,000,000.00
- Revenue This Year
- SBUX $5.76
- BMY N/A
- Revenue Next Year
- SBUX $6.97
- BMY N/A
- P/E Ratio
- SBUX $26.29
- BMY N/A
- Revenue Growth
- SBUX N/A
- BMY 7.32
- 52 Week Low
- SBUX $71.55
- BMY $39.35
- 52 Week High
- SBUX $117.46
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- SBUX 33.41
- BMY 25.85
- Support Level
- SBUX $79.89
- BMY $48.84
- Resistance Level
- SBUX $86.77
- BMY $51.60
- Average True Range (ATR)
- SBUX 4.35
- BMY 2.35
- MACD
- SBUX -0.38
- BMY -0.84
- Stochastic Oscillator
- SBUX 22.67
- BMY 3.20
About SBUX Starbucks Corporation
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries as of the end of fiscal 2024. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.